If the Miami Marlins continue their fire sale and trade away former Cy Young Sandy Alcántara in 2025, the Boston Red Sox could be the team that comes calling.

Pulse Biosciences announced today that it appointed Paul A. LaViolette, co-chair of its board, as its new CEO.

It's important, now more than ever, for Blacks to talk to their doctors about the possibility of participating in clinical ...

Terumo's solid leadership in radial access devices and expanding interventional portfolio present significant growth ...

Acquisition Strengthens Boston Scientific's Position in Minimally Invasive Treatment for Coronary Artery Disease ...

The global endoscope procedure kits market is experiencing robust growth, with a projected compound annual growth rate (CAGR) of 9.4% from 2022 to 2032, according to the latest analysis by Future ...

We recently compiled a list of the 10 Firms, Predominantly Gold Miners, Lead Wednesday Rally. In this article, we are going ...

Ten companies–predominantly gold miners–led Wednesday’s rally on Wall Street, despite the latter’s main indices closing mixed ...

Bernstein raised the firm’s price target on Boston Scientific (BSX) to $110 from $100 and keeps an Outperform rating on the shares as part of a ...

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.

Johnson & Johnson MedTech has temporarily paused all U.S. external evaluations and cases using its Varipulse pulse field ...